Skip to main content

Anika Therapeutics Value Stock - Dividend - Research Selection

Anika Therapeutics

ISIN: US0352551081, WKN: 889120

Market price date: 04.06.2021
Market price: 45,96 USD




Anika Therapeutics Fundamental data and company key figures of the share

Annual reports in USD
Key figures 07-03-2021
Cash flow
Net operating cash flow 13.065.000
Capital Expenditures -1.628.000
Free cash flow 11.437.000
Balance sheet
Total Equity 272.400.000
Liabilities & Shareholders equity 365.605.000
Income statement
Net income -23.982.000
Eps (diluted) -1,690
Diluted shares outstanding 14.220.000
Net sales/revenue 130.457.000

Fundamental ratios calculated on: 04-06-2021

Ratios
Key figures 04-06-2021
Cash flow
P/C 50,02
   
P/FC 57,14
Balance sheet
ROI-6,56
ROE74,51
Income statement
P/E-27,20
Div. Yield0,00%
P/B2,40
P/S5,01


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolANIK
Market Capitalization653.551.232,00 USD
Country
IndicesNASDAQ Comp.
Sectors
Raw Data SourceUS GAAP in Millionen USD
Stock Split
Internetwww.anikatherapeutics.com


Description of the company

Anika Therapeutics, Inc. (Anika) develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. As of December 31, 2011, Anika´s wholly owned subsidiary, Anika Therapeutics S.r.l., had over 20 products commercialized, primarily in Europe. These products are also all made from hyaluronic acid, based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.anikatherapeutics.com